Apr 1, 2026, 17:15
Chokri Ben Lamine: Differentiating Reactive from Clonal Causes in Adult Neutrophilia
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared a post on X:
“Neutrophilia approach: ANC greater than 7.5 ×10⁹/L (adult) should be classified reactive vs clonal
Step 1: confirm
- repeat CBC with differential
- review smear (toxic granulation? left shift? blasts?)
Step 2: severity and pattern
- mild (<15) | moderate (15–30) | severe (>30) | extreme (>50 = leukemoid?)
- acute vs chronic
Reactive causes (most common)
- infection (bacterial, severe viral early)
- inflammation (RA, IBD, vasculitis)
- stress (trauma, surgery, MI)
- drugs (steroids, G-CSF, lithium)
- smoking, obesity
- asplenia/post-splenectomy
Clonal / hematologic
- MPN: CML, PV, ET, MF
- CNL (rare, CSF3R+)
- AML with leukocytosis
- MDS/MPN overlap
Smear clues
- toxic granulation/Döhle bodies indicates a reactive
- basophilia with myelocyte bulge then think CML
- blasts raise concern for acute leukemia
Step 3: basic workup
- CRP/ESR
- cultures ± imaging if infection suspected
- medication review
Step 4: rule out CML early
BCR-ABL1 PCR (must not miss)
If persistent/unexplained
- JAK2 / CALR / MPL
- CSF3R if CNL suspected
- bone marrow biopsy
Red flags (urgent)
- WBC greater than 50–100
- blasts on smear
- organomegaly
- constitutional symptoms
Pearls
- neutrophilia with basophilia should be considered CML until proven otherwise
- steroid-induced neutrophilia results from demargination (no left shift)
- leukemoid reaction can mimic leukemia but LAP high
One-liner
most neutrophilia is reactive, but always exclude CML first”
Stay updated with Hemostasis Today.
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke
-
May 24, 2026, 05:48Yazan Abou-Ismail: Contributing to the Future of von Willebrand Disease Management